Geode Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $121M | Buy |
|
|||||
|
2025
Q2 | $103M | Buy |
|
|||||
|
2025
Q1 | $109M | Buy |
|
|||||
|
2024
Q4 | $77.2M | Buy |
|
|||||
|
2024
Q3 | $81.7M | Buy |
|
|||||
|
2024
Q2 | $71.2M | Buy |
|
|||||
|
2024
Q1 | $67.5M | Buy |
|
|||||
|
2023
Q4 | $65.5M | Buy |
|
|||||
|
2023
Q3 | $54.4M | Buy |
|
|||||
|
2023
Q2 | $51M | Buy |
|
|||||
|
2023
Q1 | $40.2M | Buy |
|
|||||
|
2022
Q4 | $48.2M | Buy |
|
|||||
|
2022
Q3 | $25.1M | Buy |
|
|||||
|
2022
Q2 | $20.4M | Sell |
|
|||||
|
2022
Q1 | $22.2M | Buy |
|
|||||
|
2021
Q4 | $19.2M | Buy |
|
|||||
|
2021
Q3 | $16.2M | Buy |
|
|||||
|
2021
Q2 | $32.6M | Buy |
|
|||||
|
2021
Q1 | $26.5M | Buy |
|
|||||
|
2020
Q4 | $34.8M | Buy |
|
|||||
|
2020
Q3 | $29.8M | Sell |
|
|||||
|
2020
Q2 | $35M | Buy |
|
|||||
|
2020
Q1 | $24.2M | Buy |
|
|||||
|
2019
Q4 | $38M | Buy |
|
|||||
|
2019
Q3 | $6.96M | Buy |
|
|||||
|
2019
Q2 | $7.84M | Buy |
|
|||||
|
2019
Q1 | $2.31M | Buy |
|
|||||
|
2018
Q4 | $265K | Hold |
|
|||||
|
2018
Q3 | $325K | Hold |
|
|||||
|
2018
Q2 | $301K | Hold |
|
|||||
|
2018
Q1 | $230K | Hold |
|
|||||
|
2017
Q4 | $527K | Hold |
|
|||||
|
2017
Q3 | $522K | Buy |
|
|||||
|
2017
Q2 | $399K | Buy |
|
|||||
|
2017
Q1 | $225K | Buy |
|
|||||
|
2016
Q4 | $355K | Buy |
|
|||||
|
2016
Q3 | $387K | Buy |
|
|||||
|
2016
Q2 | $364K | Buy |
|
|||||
|
2016
Q1 | $296 | Buy |
|